Dimethylamino Parthenolide Enhances the Inhibitory Effects of Gemcitabine in Human Pancreatic Cancer Cells

Tailored α-methylene-γ-butyrolactones and their effects on growth suppression in pancreatic carcinoma cells

(2010) P. Veeraraghavan Ramachandran et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo

(2010) Shuang-Jia Wang et al.   CANCER LETTERS

A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFκB and generating reactive oxygen species

(2010) Rajasubramaniam Shanmugam et al.   PROSTATE

Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)

(2009) Sundar Neelakantan et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The Role of Nuclear Factor κB in Pancreatic Cancer and the Clinical Applications of Targeted Therapy

(2009) Bryan Holcomb et al.   PANCREAS

Effect of Celecoxib and the Novel Anti-Cancer Agent, Dimethylamino-Parthenolide, in a Developmental Model of Pancreatic Cancer

(2008) Michele T. Yip-Schneider et al.   PANCREAS